Dr Kasia Owczarczyk
MBBS, MD (res), USLME, MRCP, FRCR (examination), Clinical Oncologist
Languages spoken
English
Expert in
Hepatobiliary, Lower GI, and Upper GI
Overview
Dr Kasia Owczarczyk is a consultant in clinical oncology specialising in gastro-oesophageal, rectal and hepatobiliary cancers. She currently works as a consultant in Guy's and St Thomas' NHS Foundation Trust. In addition, she is part of the MR Linac SABR group at the London Cromwell Hospital.
She trained in clinical oncology at University College Hospital London and Mount Vernon Cancer Centre. She has completed a research MD, a post-doctoral fellowship at Genentech, South San Francisco and a clinical fellowship in cancer imaging at King's College London.
She was appointed as an honorary senior clinical lecturer at King's College London in 2018 and awarded the Guy's Cancer Career Development and Innovation Award in 2019. Her research includes publications in the Science TM, JCI Insights and Radiotherapy Oncology journals.
Career positions
- Consultant in Clinical Oncology, Guy's and St Thomas NHS Trust
- Senior Honorary Clinical Lecturer, KCL
Expertise and interests
- Chemoradiotherapy and radiotherapy treatment of gastro-oesophageal cancer
- Chemoradiotherapy and radiotherapy treatment of rectal cancer
- Chemoradiotherapy treatment of pancreatic cancer
- Stereotactic body radiotherapy (SBRT) including MRI guided SBRT
- Intraluminal HDR brachytherapy of oesophageal cancer
- predictive markers
- Radiomics
- Image guided radiotherapy
- Adaptive radiotherapy
- Stereotactic MRI guided ablative radiotherapy (SMART)
- Normal tissue toxicity
- Predictive imaging markers including radiomics
Awards
- Guy's Cancer Career Development and Innovation Award, 2019
Professional memberships
- PD-0502 Stereotactic MR guided online adaptive radiotherapy for abdominal and pelvic lymph node metastases
- ASO Visual Abstract: Clinical Relevance of the Tumor Location-Modified Laurén Classification System of Gastric Cancer in a Western Population
- Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population